Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 1
1992 2
1994 4
1995 3
1996 10
1997 5
1998 5
1999 2
2000 1
2001 3
2002 1
2003 4
2004 3
2005 5
2006 5
2007 5
2008 4
2009 12
2010 6
2011 6
2012 10
2013 8
2014 8
2015 8
2016 9
2017 9
2018 15
2019 8
2020 8
2021 13
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

180 results
Results by year
Filters applied: . Clear all
Page 1
Prise en charge des patients atteints de maladies rhumatismales pendant la pandémie de COVID-19 : la Société française de rhumatologie répond aux questions fréquentes posées jusqu’en mai 2020.
Richez C, Flipo RM, Berenbaum F, Cantagrel A, Claudepierre P, Debiais F, Dieudé P, Goupille P, Roux C, Schaeverbeke T, Wendling D, Pham T, Thomas T. Richez C, et al. Among authors: claudepierre p. Rev Rhum Ed Fr. 2021 Mar;88(2):93-100. doi: 10.1016/j.rhum.2021.01.013. Epub 2021 Jan 18. Rev Rhum Ed Fr. 2021. PMID: 33488063 Free PMC article. French.
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial.
Molto A, López-Medina C, Van den Bosch FE, Boonen A, Webers C, Dernis E, van Gaalen FA, Soubrier M, Claudepierre P, Baillet A, Starmans-Kool M, Spoorenberg A, Jacques P, Carron P, Joos R, Lenaerts J, Gossec L, Pouplin S, Ruyssen-Witrand A, Sparsa L, van Tubergen A, van der Heijde D, Dougados M. Molto A, et al. Among authors: claudepierre p. Ann Rheum Dis. 2021 Nov;80(11):1436-1444. doi: 10.1136/annrheumdis-2020-219585. Epub 2021 May 6. Ann Rheum Dis. 2021. PMID: 33958325 Free PMC article. Clinical Trial.
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.
Avouac J, Drumez E, Hachulla E, Seror R, Georgin-Lavialle S, El Mahou S, Pertuiset E, Pham T, Marotte H, Servettaz A, Domont F, Chazerain P, Devaux M, Claudepierre P, Langlois V, Mekinian A, Maria ATJ, Banneville B, Fautrel B, Pouchot J, Thomas T, Flipo RM, Richez C; FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors; FAIR/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors. Avouac J, et al. Among authors: claudepierre p. Lancet Rheumatol. 2021 Jun;3(6):e419-e426. doi: 10.1016/S2665-9913(21)00059-X. Epub 2021 Mar 25. Lancet Rheumatol. 2021. PMID: 33786454 Free PMC article.
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
Izadi Z, Brenner EJ, Mahil SK, Dand N, Yiu ZZN, Yates M, Ungaro RC, Zhang X, Agrawal M, Colombel JF, Gianfrancesco MA, Hyrich KL, Strangfeld A, Carmona L, Mateus EF, Lawson-Tovey S, Klingberg E, Cuomo G, Caprioli M, Cruz-Machado AR, Mazeda Pereira AC, Hasseli R, Pfeil A, Lorenz HM, Hoyer BF, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Seet AM, Al Emadi S, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Isnardi CA, Quintana R, Soriano ER, Hsu TY, D'Silva KM, Sparks JA, Patel NJ, Xavier RM, Marques CDL, Kakehasi AM, Flipo RM, Claudepierre P, Cantagrel A, Goupille P, Wallace ZS, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Griffiths CEM, Barker JN, Smith CH, Yazdany J, Kappelman MD; Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD); and the COVID-19 Global Rheumatology Allianc; Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD); and the COVID-19 Global Rheumatology Alliance (GRA). Izadi Z, et al. Among authors: claudepierre p. JAMA Netw Open. 2021 Oct 1;4(10):e2129639. doi: 10.1001/jamanetworkopen.2021.29639. JAMA Netw Open. 2021. PMID: 34661663 Free PMC article.
[Management of spondyloarthritis].
Claudepierre P. Claudepierre P. Rev Prat. 2018 Sep;68(7):740-746. Rev Prat. 2018. PMID: 30869323 French.
Treatment strategies for psoriatic arthritis.
Schemoul J, Poulain C, Claudepierre P. Schemoul J, et al. Among authors: claudepierre p. Joint Bone Spine. 2018 Oct;85(5):537-544. doi: 10.1016/j.jbspin.2017.11.001. Epub 2017 Nov 16. Joint Bone Spine. 2018. PMID: 29155104 Review.
Mortality in spondylarthritis.
Prati C, Claudepierre P, Pham T, Wendling D. Prati C, et al. Among authors: claudepierre p. Joint Bone Spine. 2011 Oct;78(5):466-70. doi: 10.1016/j.jbspin.2011.02.012. Epub 2011 Mar 29. Joint Bone Spine. 2011. PMID: 21450507 Review.
[Psoriatic arthritis].
Claudepierre P, Bagot M. Claudepierre P, et al. Ann Dermatol Venereol. 2008 Feb;135 Suppl 4:S263-8. doi: 10.1016/S0151-9638(08)70546-5. Ann Dermatol Venereol. 2008. PMID: 18466795 French.
Non-radiographic axial spondyloarthritis: what is it?
Fianyo E, Wendling D, Poulain C, Farrenq V, Claudepierre P. Fianyo E, et al. Among authors: claudepierre p. Clin Exp Rheumatol. 2014 Jan-Feb;32(1):1-4. Epub 2013 Sep 10. Clin Exp Rheumatol. 2014. PMID: 24021580 Review.
High prevalence of small intestinal bacterial overgrowth (SIBO) in spondylarthropathy.
Laroche JM, Kapel N, Benahmed N, Claudepierre P, Chevalier X, Barbot-Trystram L. Laroche JM, et al. Among authors: claudepierre p. Clin Exp Rheumatol. 2021 May-Jun;39(3):703. doi: 10.55563/clinexprheumatol/nyanfu. Epub 2021 Jan 11. Clin Exp Rheumatol. 2021. PMID: 33427609 Free article. No abstract available.
180 results